Partner Content Partner Content What's Pharma’s next step? – AI Pharma Innovation Summit Real World Application of AI in Pharma's R&D
News Sanofi/Regeneron PCSK9 lowers cholesterol in diabetes patien... Companies awaiting CV outcomes trial, and court decision in patent case
News Novo hopes hypoglycaemia data will boost Tresiba Lower severe hypo risk compared with Lantus - but no cardiac benefit.
News Sanofi, Regeneron aim to undercut rivals with new RA drug New drug will be sold at around 30% discount to rivals.
News Sanofi beats expectations, driven by rare diseases and vacci... But sales of key insulin fall amid biosimilar competition.
News Report links Sanofi epilepsy drug with thousands of birth de... Depakine and generics linked with defects including spina bifida.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.